ALX ONCOLOGY HOLDINGS INC Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2021-03-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 100.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2020-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 100.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2020-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 100.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2020-07-21: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock Dividends, Income Statement Impact | Preferred Stock Dividends and Other Adjustments |
|---|---|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | 100.00M shares 10-Q · filed 2021-05-17 | 0.00 shares 10-Q · filed 2021-05-17 | 0.00 shares 10-Q · filed 2021-05-17 | ||
| 2020-12-31 | $0.00 10-Q · filed 2021-05-17 | 100.00M shares 10-Q · filed 2021-05-17 | 0.00 shares 10-Q · filed 2021-05-17 | 0.00 shares 10-Q · filed 2021-05-17 | $5.20M 10-K · filed 2023-03-09 | $5.20M 10-K · filed 2023-03-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | 100.00M shares 10-Q · filed 2020-11-12 | 0.00 shares 10-Q · filed 2020-11-12 | 0.00 shares 10-Q · filed 2020-11-12 | $578.00K 10-Q · filed 2021-11-12 | $578.00K 10-Q · filed 2021-11-12 |
| 2020-07-21 | $0.00 10-Q · filed 2026-08-06 | |||||
| 2020-06-30 | $2.64M 10-Q · filed 2021-08-12 | $2.64M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $1.98M 10-Q · filed 2021-05-17 | $1.98M 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-18 | 100.00M shares 10-K · filed 2021-03-18 | 0.00 shares 10-K · filed 2021-03-18 | 0.00 shares 10-K · filed 2021-03-18 | $4.03M 10-K · filed 2022-02-28 | $4.03M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.07M 10-Q · filed 2020-11-12 | $1.07M 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $981.00K 10-Q · filed 2020-08-27 | $981.00K 10-Q · filed 2020-08-27 | ||||
| 2018-12-31 | $3.67M 10-K · filed 2021-03-18 | $3.67M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |